Cite Filings / RNAZ / 0001104659-23-072206

Feed Companies Filings Check

Sign in

SC 13D/A

Beneficial Ownership Report

Transcode Therapeutics, Inc. Filed 2023-06-16 Acc 0001104659-23-072206

Documents 1

SC 13D/A Beneficial Ownership Report , tm2318994d1_sc13da.htm

Around this filing

2023-10-10 SC 13D/A Beneficial Ownership Report
2023-06-22 4 Chief Executive Officer bought 18,607 shares at an average $2.62 ($48,665)
2023-06-16 SC 13D/A Beneficial Ownership Report
2023-06-14 4/A Chief Executive Officer bought 19,000 shares at $2.76 ($52,440)
2023-06-13 4 Chief Executive Officer bought 19,000 shares at $2.76 ($52,440)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2318994d1_sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…